propofol has been researched along with Craniopharyngioma in 2 studies
Propofol: An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.
propofol : A phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group.
Craniopharyngioma: A benign pituitary-region neoplasm that originates from Rathke's pouch. The two major histologic and clinical subtypes are adamantinous (or classical) craniopharyngioma and papillary craniopharyngioma. The adamantinous form presents in children and adolescents as an expanding cystic lesion in the pituitary region. The cystic cavity is filled with a black viscous substance and histologically the tumor is composed of adamantinomatous epithelium and areas of calcification and necrosis. Papillary craniopharyngiomas occur in adults, and histologically feature a squamous epithelium with papillations. (From Joynt, Clinical Neurology, 1998, Ch14, p50)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Propofol and sevoflurane could reduce the levels of hormones intraoperatively and postoperatively in pediatric patients with craniopharyngioma." | 9.69 | Propofol suppresses hormones levels more obviously than sevoflurane in pediatric patients with craniopharyngioma: A prospective randomized controlled clinical trial. ( Gao, J; Pang, Y; Sun, Y; Wang, M; Xiong, J; Zhou, Y, 2023) |
| "Propofol and sevoflurane could reduce the levels of hormones intraoperatively and postoperatively in pediatric patients with craniopharyngioma." | 5.69 | Propofol suppresses hormones levels more obviously than sevoflurane in pediatric patients with craniopharyngioma: A prospective randomized controlled clinical trial. ( Gao, J; Pang, Y; Sun, Y; Wang, M; Xiong, J; Zhou, Y, 2023) |
| "Propofol titration is a key issue in GKS." | 1.39 | How to control propofol infusion in pediatric patients undergoing gamma knife radiosurgery. ( Hayashi, M; Iseki, H; Kamata, K; Muragaki, Y; Okada, Y; Ozaki, M, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xiong, J | 1 |
| Wang, M | 1 |
| Gao, J | 1 |
| Zhou, Y | 1 |
| Pang, Y | 1 |
| Sun, Y | 1 |
| Kamata, K | 1 |
| Hayashi, M | 1 |
| Muragaki, Y | 1 |
| Iseki, H | 1 |
| Okada, Y | 1 |
| Ozaki, M | 1 |
1 trial available for propofol and Craniopharyngioma
| Article | Year |
|---|---|
Propofol suppresses hormones levels more obviously than sevoflurane in pediatric patients with craniopharyngioma: A prospective randomized controlled clinical trial.
Topics: Adrenocorticotropic Hormone; Anesthesia, General; Anesthetics, Inhalation; Child; Craniopharyngioma; | 2023 |
1 other study available for propofol and Craniopharyngioma
| Article | Year |
|---|---|
How to control propofol infusion in pediatric patients undergoing gamma knife radiosurgery.
Topics: Anesthetics, Intravenous; Arteriovenous Malformations; Child; Child, Preschool; Craniopharyngioma; D | 2013 |